News

Read more here.

Read more here.

Click here to register!

New product launch

Read more here.

In London, UK - Jan. 22 2013

New Product Launch

On Nov. 27, 2012 in London, UK

Distribution in North America

Bio-Strategy Ltd new exclusive distributor

17-18 Sept, 2012 in Malmö, Sweden

Wieslab Netherlands

Invitation for Participation

Finnish healthcare company Biohit Plc. signed a distribution contract on Thursday May 24th with Euro Diagnostica.

EURIA Chromogranin B

Pertusscan PT IgG

Euro Diagnostica supports the session dedicated to benefits of anti-CCP2 testing in effective clinical diagnosis of rheumatoid arthritis

In a recent literature review on the risk of cancer as a result of anti-TNF alpha treatmet the conclusion was "With these caveats in mind, it is interesting to note that these studies revealed little or no cancer risk associated with TNF inhibitors.

In a recent letter the problem of HCV infection clinically mimicking rheumatoid arthritis regarding joint engagement has been highlighted.

New Web Launch

Recent studies has shown that deficiency in the MBL complement pathway suggest a worse prognosis in paediatric oncology patients.

Partnership Euro-Diagnostica and Dynex

Unique Complement assessment

Wegener’s granulomatosis change name

Rheumatoid arthritis is associated with increased risk to develop certain forms of cancer